# Benjamin Rix Brooks

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/benjamin-rix-brooks/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,822 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 55 |
| i10-index | 125 |
| Last Known Institution | Royal Sussex County Hospital |
| OpenAlex ID | https://openalex.org/A5032745219 |
| ORCID iD | 0000-0002-1914-5061 |
| Works | 244 |

## Researcher papers

- [El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis](https://scholariq.org/papers/el-escorial-revisited-revised-criteria-for-the-diagnosis-of-amyotrophic-lateral/)
- [El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis](https://scholariq.org/papers/el-escorial-world-federation-of-neurology-criteria-for-the-diagnosis-of/)
- [Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia](https://scholariq.org/papers/mutations-in-ubqln2-cause-dominant-x-linked-juvenile-and-adult-onset-als-and-als/)
- [Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review) \[RETIRED\]](https://scholariq.org/papers/practice-parameter-the-care-of-the-patient-with-amyotrophic-lateral-sclerosis-an/)
- [Controversies and priorities in amyotrophic lateral sclerosis](https://scholariq.org/papers/controversies-and-priorities-in-amyotrophic-lateral-sclerosis/)
- [Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine](https://scholariq.org/papers/treatment-of-pseudobulbar-affect-in-als-with-dextromethorphan-quinidine/)
- [Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect](https://scholariq.org/papers/dextromethorphan-plus-ultra-low-dose-quinidine-reduces-pseudobulbar-affect/)
- [Progressive Multifocal Leukoencephalopathy](https://scholariq.org/papers/progressive-multifocal-leukoencephalopathy-2/)
- [Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?](https://scholariq.org/papers/clinical-trials-in-amyotrophic-lateral-sclerosis-why-so-many-negative-trials-and/)
- [Progressive Multifocal Leukoencephalopathy](https://scholariq.org/papers/progressive-multifocal-leukoencephalopathy/)
- [Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/safety-and-efficacy-of-ceftriaxone-for-amyotrophic-lateral-sclerosis-a-multi/)
- [The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis](https://scholariq.org/papers/the-effects-of-intervention-with-intravenous-edaravone-in-study-19-on/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Dysphagia Assessment and Management](https://scholariq.org/topics/dysphagia-assessment-and-management/)

## Researcher university

- [Royal Sussex County Hospital](https://scholariq.org/institutions/royal-sussex-county-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.